Cargando…

Microfluidics for 3D Cell and Tissue Cultures: Microfabricative and Ethical Aspects Updates

The necessity to improve in vitro cell screening assays is becoming ever more important. Pharmaceutical companies, research laboratories and hospitals require technologies that help to speed up conventional screening and therapeutic procedures to produce more data in a short time in a realistic and...

Descripción completa

Detalles Bibliográficos
Autores principales: Limongi, Tania, Guzzi, Francesco, Parrotta, Elvira, Candeloro, Patrizio, Scalise, Stefania, Lucchino, Valeria, Gentile, Francesco, Tirinato, Luca, Coluccio, Maria Laura, Torre, Bruno, Allione, Marco, Marini, Monica, Susa, Francesca, Fabrizio, Enzo Di, Cuda, Giovanni, Perozziello, Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139493/
https://www.ncbi.nlm.nih.gov/pubmed/35626736
http://dx.doi.org/10.3390/cells11101699
_version_ 1784714872077942784
author Limongi, Tania
Guzzi, Francesco
Parrotta, Elvira
Candeloro, Patrizio
Scalise, Stefania
Lucchino, Valeria
Gentile, Francesco
Tirinato, Luca
Coluccio, Maria Laura
Torre, Bruno
Allione, Marco
Marini, Monica
Susa, Francesca
Fabrizio, Enzo Di
Cuda, Giovanni
Perozziello, Gerardo
author_facet Limongi, Tania
Guzzi, Francesco
Parrotta, Elvira
Candeloro, Patrizio
Scalise, Stefania
Lucchino, Valeria
Gentile, Francesco
Tirinato, Luca
Coluccio, Maria Laura
Torre, Bruno
Allione, Marco
Marini, Monica
Susa, Francesca
Fabrizio, Enzo Di
Cuda, Giovanni
Perozziello, Gerardo
author_sort Limongi, Tania
collection PubMed
description The necessity to improve in vitro cell screening assays is becoming ever more important. Pharmaceutical companies, research laboratories and hospitals require technologies that help to speed up conventional screening and therapeutic procedures to produce more data in a short time in a realistic and reliable manner. The design of new solutions for test biomaterials and active molecules is one of the urgent problems of preclinical screening and the limited correlation between in vitro and in vivo data remains one of the major issues. The establishment of the most suitable in vitro model provides reduction in times, costs and, last but not least, in the number of animal experiments as recommended by the 3Rs (replace, reduce, refine) ethical guiding principles for testing involving animals. Although two-dimensional (2D) traditional cell screening assays are generally cheap and practical to manage, they have strong limitations, as cells, within the transition from the three-dimensional (3D) in vivo to the 2D in vitro growth conditions, do not properly mimic the real morphologies and physiology of their native tissues. In the study of human pathologies, especially, animal experiments provide data closer to what happens in the target organ or apparatus, but they imply slow and costly procedures and they generally do not fully accomplish the 3Rs recommendations, i.e., the amount of laboratory animals and the stress that they undergo must be minimized. Microfluidic devices seem to offer different advantages in relation to the mentioned issues. This review aims to describe the critical issues connected with the conventional cells culture and screening procedures, showing what happens in the in vivo physiological micro and nano environment also from a physical point of view. During the discussion, some microfluidic tools and their components are described to explain how these devices can circumvent the actual limitations described in the introduction.
format Online
Article
Text
id pubmed-9139493
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91394932022-05-28 Microfluidics for 3D Cell and Tissue Cultures: Microfabricative and Ethical Aspects Updates Limongi, Tania Guzzi, Francesco Parrotta, Elvira Candeloro, Patrizio Scalise, Stefania Lucchino, Valeria Gentile, Francesco Tirinato, Luca Coluccio, Maria Laura Torre, Bruno Allione, Marco Marini, Monica Susa, Francesca Fabrizio, Enzo Di Cuda, Giovanni Perozziello, Gerardo Cells Review The necessity to improve in vitro cell screening assays is becoming ever more important. Pharmaceutical companies, research laboratories and hospitals require technologies that help to speed up conventional screening and therapeutic procedures to produce more data in a short time in a realistic and reliable manner. The design of new solutions for test biomaterials and active molecules is one of the urgent problems of preclinical screening and the limited correlation between in vitro and in vivo data remains one of the major issues. The establishment of the most suitable in vitro model provides reduction in times, costs and, last but not least, in the number of animal experiments as recommended by the 3Rs (replace, reduce, refine) ethical guiding principles for testing involving animals. Although two-dimensional (2D) traditional cell screening assays are generally cheap and practical to manage, they have strong limitations, as cells, within the transition from the three-dimensional (3D) in vivo to the 2D in vitro growth conditions, do not properly mimic the real morphologies and physiology of their native tissues. In the study of human pathologies, especially, animal experiments provide data closer to what happens in the target organ or apparatus, but they imply slow and costly procedures and they generally do not fully accomplish the 3Rs recommendations, i.e., the amount of laboratory animals and the stress that they undergo must be minimized. Microfluidic devices seem to offer different advantages in relation to the mentioned issues. This review aims to describe the critical issues connected with the conventional cells culture and screening procedures, showing what happens in the in vivo physiological micro and nano environment also from a physical point of view. During the discussion, some microfluidic tools and their components are described to explain how these devices can circumvent the actual limitations described in the introduction. MDPI 2022-05-20 /pmc/articles/PMC9139493/ /pubmed/35626736 http://dx.doi.org/10.3390/cells11101699 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Limongi, Tania
Guzzi, Francesco
Parrotta, Elvira
Candeloro, Patrizio
Scalise, Stefania
Lucchino, Valeria
Gentile, Francesco
Tirinato, Luca
Coluccio, Maria Laura
Torre, Bruno
Allione, Marco
Marini, Monica
Susa, Francesca
Fabrizio, Enzo Di
Cuda, Giovanni
Perozziello, Gerardo
Microfluidics for 3D Cell and Tissue Cultures: Microfabricative and Ethical Aspects Updates
title Microfluidics for 3D Cell and Tissue Cultures: Microfabricative and Ethical Aspects Updates
title_full Microfluidics for 3D Cell and Tissue Cultures: Microfabricative and Ethical Aspects Updates
title_fullStr Microfluidics for 3D Cell and Tissue Cultures: Microfabricative and Ethical Aspects Updates
title_full_unstemmed Microfluidics for 3D Cell and Tissue Cultures: Microfabricative and Ethical Aspects Updates
title_short Microfluidics for 3D Cell and Tissue Cultures: Microfabricative and Ethical Aspects Updates
title_sort microfluidics for 3d cell and tissue cultures: microfabricative and ethical aspects updates
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139493/
https://www.ncbi.nlm.nih.gov/pubmed/35626736
http://dx.doi.org/10.3390/cells11101699
work_keys_str_mv AT limongitania microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT guzzifrancesco microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT parrottaelvira microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT candeloropatrizio microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT scalisestefania microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT lucchinovaleria microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT gentilefrancesco microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT tirinatoluca microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT colucciomarialaura microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT torrebruno microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT allionemarco microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT marinimonica microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT susafrancesca microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT fabrizioenzodi microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT cudagiovanni microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates
AT perozziellogerardo microfluidicsfor3dcellandtissueculturesmicrofabricativeandethicalaspectsupdates